{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T19:18:45Z","timestamp":1795029525474,"version":"4.10.2"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,4,21]],"date-time":"2023-04-21T00:00:00Z","timestamp":1682035200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,4,21]],"date-time":"2023-04-21T00:00:00Z","timestamp":1682035200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Projects of Scientific and Technological Innovation in Fujian Province","award":["2021G02023"],"award-info":[{"award-number":["2021G02023"]}]},{"name":"Projects of Scientific and Technological Innovation in Fujian Province","award":["2022G028"],"award-info":[{"award-number":["2022G028"]}]},{"DOI":"10.13039\/501100003392","name":"Natural Science Foundation of Fujian Province","doi-asserted-by":"publisher","award":["2022J01172"],"award-info":[{"award-number":["2022J01172"]}],"id":[{"id":"10.13039\/501100003392","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003392","name":"Natural Science Foundation of Fujian Province","doi-asserted-by":"publisher","award":["2020J01176"],"award-info":[{"award-number":["2020J01176"]}],"id":[{"id":"10.13039\/501100003392","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Innovation and Entrepreneurship Project of Fujian Normal University","award":["I202102008"],"award-info":[{"award-number":["I202102008"]}]},{"name":"Innovation and Entrepreneurship Project of Fujian Normal University","award":["I202003009"],"award-info":[{"award-number":["I202003009"]}]},{"name":"Special Funds of the Central Government Guiding Local Science and Technology Development","award":["2020L3008"],"award-info":[{"award-number":["2020L3008"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Irinotecan is a topoisomerase I inhibitor which has been widely used to combat several solid tumors, whereas irinotecan therapy can induce liver injury. Liver injury generally leads to tissue hypoxia, and hypoxia-inducible factor-1\u03b1 (HIF-1\u03b1), a pivotal transcription factor, mediates adaptive pathophysiological responses to lower oxygen condition. Previous studies have reported a relationship between HIF-1\u03b1 and autophagy, and autophagy impairment is a common characteristic in a variety of diseases. Here, irinotecan (50\u00a0mg\/kg) was employed on mice, and HepG2 and L-02 cells were cultured with irinotecan (10, 20 and 40\u00a0\u03bcM). In vivo study, we found that irinotecan treatment increased final liver index, serum aminotransferase level and hepatic lipid accumulation. Impaired autophagic flux and activation of HIF-1\u03b1\/BNIP3 pathway were also demonstrated in the liver of irinotecan-treated mice. Moreover, irinotecan treatment significantly deteriorated hepatic oxidative stress, evidenced by increased MDA and ROS contents, as well as decreased GSH-Px, SOD and CAT contents. Interestingly, protein levels of NLRP3, cleaved-caspase 1 and IL-1\u03b2 were enhanced in the liver of mice injected with irinotecan. In vitro study, irinotecan-treated HepG2 and L-02 cells also showed impaired autophagic flux, while HIF-1\u03b1 inhibition efficaciously removed the accumulated autophagosomes induced by irinotecan. Additionally, irinotecan treatment aggravated lipid accumulation in HepG2 and L-02 cells, and HIF-1\u03b1 inhibition reversed the effect of irinotecan. Furthermore, HIF-1\u03b1 inhibition weakened irinotecan-induced NLRP3 inflammasome activation in HepG2 cells. Taken together, our results suggest that irinotecan induces liver injury by orchestrating autophagy via HIF-1\u03b1\/BNIP3 pathway, and HIF-1\u03b1 inhibition could alleviate irinotecan-induced lipid accumulation in HepG2 and L-02 cells, which will provide a new clue and direction for the prevention of side effects of clinical chemotherapy drugs.<\/jats:p>","DOI":"10.1038\/s41598-023-33848-y","type":"journal-article","created":{"date-parts":[[2023,4,21]],"date-time":"2023-04-21T06:03:17Z","timestamp":1682056997000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Contribution of HIF-1\u03b1\/BNIP3-mediated autophagy to lipid accumulation during irinotecan-induced liver injury"],"prefix":"10.1038","volume":"13","author":[{"given":"Congjian","family":"Shi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenghong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renfeng","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhengchao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,4,21]]},"reference":[{"key":"33848_CR1","doi-asserted-by":"publisher","first-page":"2085","DOI":"10.2174\/0929867325666180622141101","volume":"26","author":"RZ Hahn","year":"2019","unstructured":"Hahn, R. Z. et al. Pharmacokinetic and pharmacogenetic markers of irinotecan toxicity. Curr. Med. Chem. 26, 2085\u20132107. https:\/\/doi.org\/10.2174\/0929867325666180622141101 (2019).","journal-title":"Curr. Med. Chem."},{"key":"33848_CR2","doi-asserted-by":"publisher","first-page":"101606","DOI":"10.1016\/j.clinre.2020.101606","volume":"45","author":"M Araz","year":"2021","unstructured":"Araz, M., Kilinc, F., Kerimoglu, U., Keskin, M. & Kucukkartallar, T. Irinotecan-induced NASH and liver failure. Clin. Res. Hepatol. Gastroenterol. 45, 101606. https:\/\/doi.org\/10.1016\/j.clinre.2020.101606 (2021).","journal-title":"Clin. Res. Hepatol. Gastroenterol."},{"key":"33848_CR3","doi-asserted-by":"publisher","first-page":"1217","DOI":"10.1016\/j.jhep.2016.06.006","volume":"65","author":"KM van Mierlo","year":"2016","unstructured":"van Mierlo, K. M., Schaap, F. G., Dejong, C. H. & Olde Damink, S. W. Liver resection for cancer: New developments in prediction, prevention and management of postresectional liver failure. J. Hepatol. 65, 1217\u20131231. https:\/\/doi.org\/10.1016\/j.jhep.2016.06.006 (2016).","journal-title":"J. Hepatol."},{"key":"33848_CR4","doi-asserted-by":"publisher","first-page":"1188","DOI":"10.1002\/bjs.7630","volume":"98","author":"JS Hammond","year":"2011","unstructured":"Hammond, J. S., Guha, I. N., Beckingham, I. J. & Lobo, D. N. Prediction, prevention and management of postresection liver failure. Br. J. Surg. 98, 1188\u20131200. https:\/\/doi.org\/10.1002\/bjs.7630 (2011).","journal-title":"Br. J. Surg."},{"key":"33848_CR5","doi-asserted-by":"publisher","first-page":"754891","DOI":"10.3389\/fonc.2021.754891","volume":"11","author":"J Han","year":"2021","unstructured":"Han, J., Zhang, J. & Zhang, C. Irinotecan-induced steatohepatitis: Current insights. Front. Oncol. 11, 754891. https:\/\/doi.org\/10.3389\/fonc.2021.754891 (2021).","journal-title":"Front. Oncol."},{"key":"33848_CR6","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1016\/j.aohep.2019.11.012","volume":"19","author":"L Meunier","year":"2020","unstructured":"Meunier, L. & Larrey, D. Chemotherapy-associated steatohepatitis. Ann. Hepatol. 19, 597\u2013601. https:\/\/doi.org\/10.1016\/j.aohep.2019.11.012 (2020).","journal-title":"Ann. Hepatol."},{"key":"33848_CR7","doi-asserted-by":"publisher","first-page":"578001","DOI":"10.3389\/fmed.2020.578001","volume":"7","author":"SC Isaza","year":"2020","unstructured":"Isaza, S. C. et al. Hypoxia and non-alcoholic fatty liver disease. Front. Med. (Lausanne) 7, 578001. https:\/\/doi.org\/10.3389\/fmed.2020.578001 (2020).","journal-title":"Front. Med. (Lausanne)"},{"key":"33848_CR8","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.bbrc.2021.01.002","volume":"540","author":"H Cai","year":"2021","unstructured":"Cai, H., Bai, Z. & Ge, R. L. Hypoxia-inducible factor-2 promotes liver fibrosis in non-alcoholic steatohepatitis liver disease via the NF-kappaB signalling pathway. Biochem. Biophys. Res. Commun. 540, 67\u201374. https:\/\/doi.org\/10.1016\/j.bbrc.2021.01.002 (2021).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"33848_CR9","doi-asserted-by":"publisher","first-page":"E710","DOI":"10.1152\/ajpendo.00052.2019","volume":"317","author":"J Chen","year":"2019","unstructured":"Chen, J. et al. Hypoxia exacerbates nonalcoholic fatty liver disease via the HIF-2alpha\/PPARalpha pathway. Am. J. Physiol. Endocrinol. Metab. 317, E710\u2013E722. https:\/\/doi.org\/10.1152\/ajpendo.00052.2019 (2019).","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"33848_CR10","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1002\/hep.30215","volume":"69","author":"X Wang","year":"2019","unstructured":"Wang, X. et al. Macrophage-specific hypoxia-inducible factor-1alpha contributes to impaired autophagic flux in nonalcoholic steatohepatitis. Hepatology 69, 545\u2013563. https:\/\/doi.org\/10.1002\/hep.30215 (2019).","journal-title":"Hepatology"},{"key":"33848_CR11","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1016\/j.molcel.2010.09.022","volume":"40","author":"AJ Majmundar","year":"2010","unstructured":"Majmundar, A. J., Wong, W. J. & Simon, M. C. Hypoxia-inducible factors and the response to hypoxic stress. Mol. Cell 40, 294\u2013309. https:\/\/doi.org\/10.1016\/j.molcel.2010.09.022 (2010).","journal-title":"Mol. Cell"},{"key":"33848_CR12","doi-asserted-by":"publisher","first-page":"886","DOI":"10.1016\/j.jhep.2018.05.021","volume":"69","author":"T Shao","year":"2018","unstructured":"Shao, T. et al. Intestinal HIF-1alpha deletion exacerbates alcoholic liver disease by inducing intestinal dysbiosis and barrier dysfunction. J. Hepatol. 69, 886\u2013895. https:\/\/doi.org\/10.1016\/j.jhep.2018.05.021 (2018).","journal-title":"J. Hepatol."},{"key":"33848_CR13","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1111\/liv.12633","volume":"35","author":"T Csak","year":"2015","unstructured":"Csak, T. et al. microRNA-122 regulates hypoxia-inducible factor-1 and vimentin in hepatocytes and correlates with fibrosis in diet-induced steatohepatitis. Liver Int. 35, 532\u2013541. https:\/\/doi.org\/10.1111\/liv.12633 (2015).","journal-title":"Liver Int."},{"key":"33848_CR14","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1016\/j.molcel.2010.09.023","volume":"40","author":"G Kroemer","year":"2010","unstructured":"Kroemer, G., Marino, G. & Levine, B. Autophagy and the integrated stress response. Mol. Cell 40, 280\u2013293. https:\/\/doi.org\/10.1016\/j.molcel.2010.09.023 (2010).","journal-title":"Mol. Cell"},{"key":"33848_CR15","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.ejphar.2019.02.005","volume":"850","author":"C Shi","year":"2019","unstructured":"Shi, C. et al. Acetaminophen aggravates fat accumulation in NAFLD by inhibiting autophagy via the AMPK\/mTOR pathway. Eur. J. Pharmacol. 850, 15\u201322. https:\/\/doi.org\/10.1016\/j.ejphar.2019.02.005 (2019).","journal-title":"Eur. J. Pharmacol."},{"key":"33848_CR16","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1146\/annurev-nutr-071813-105336","volume":"35","author":"N Martinez-Lopez","year":"2015","unstructured":"Martinez-Lopez, N. & Singh, R. Autophagy and lipid droplets in the liver. Annu. Rev. Nutr. 35, 215\u2013237. https:\/\/doi.org\/10.1146\/annurev-nutr-071813-105336 (2015).","journal-title":"Annu. Rev. Nutr."},{"key":"33848_CR17","doi-asserted-by":"publisher","first-page":"2415","DOI":"10.1080\/15548627.2020.1827779","volume":"17","author":"DH Lee","year":"2021","unstructured":"Lee, D. H. et al. Mir214-3p and Hnf4a\/Hnf4alpha reciprocally regulate Ulk1 expression and autophagy in nonalcoholic hepatic steatosis. Autophagy 17, 2415\u20132431. https:\/\/doi.org\/10.1080\/15548627.2020.1827779 (2021).","journal-title":"Autophagy"},{"key":"33848_CR18","doi-asserted-by":"publisher","first-page":"1631","DOI":"10.1080\/15384101.2015.1038685","volume":"14","author":"K Wang","year":"2015","unstructured":"Wang, K. Autophagy and apoptosis in liver injury. Cell Cycle 14, 1631\u20131642. https:\/\/doi.org\/10.1080\/15384101.2015.1038685 (2015).","journal-title":"Cell Cycle"},{"key":"33848_CR19","doi-asserted-by":"publisher","first-page":"1764929","DOI":"10.1155\/2021\/1764929","volume":"2021","author":"Z Tang","year":"2021","unstructured":"Tang, Z. et al. HIF-1alpha activation promotes luteolysis by enhancing ROS levels in the corpus luteum of pseudopregnant rats. Oxid. Med. Cell Longev. 2021, 1764929. https:\/\/doi.org\/10.1155\/2021\/1764929 (2021).","journal-title":"Oxid. Med. Cell Longev."},{"key":"33848_CR20","doi-asserted-by":"publisher","first-page":"746","DOI":"10.1136\/gutjnl-2016-312485","volume":"67","author":"A Mahli","year":"2018","unstructured":"Mahli, A. et al. ERK activation and autophagy impairment are central mediators of irinotecan-induced steatohepatitis. Gut 67, 746\u2013756. https:\/\/doi.org\/10.1136\/gutjnl-2016-312485 (2018).","journal-title":"Gut"},{"key":"33848_CR21","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1007\/s00280-014-2434-8","volume":"74","author":"ML Costa","year":"2014","unstructured":"Costa, M. L. et al. Chemotherapy-associated steatohepatitis induced by irinotecan: A novel animal model. Cancer Chemother. Pharmacol. 74, 711\u2013720. https:\/\/doi.org\/10.1007\/s00280-014-2434-8 (2014).","journal-title":"Cancer Chemother. Pharmacol."},{"key":"33848_CR22","doi-asserted-by":"publisher","first-page":"3196","DOI":"10.7150\/thno.71029","volume":"12","author":"W Jin","year":"2022","unstructured":"Jin, W. et al. Neuronal STAT3\/HIF-1alpha\/PTRF axis-mediated bioenergetic disturbance exacerbates cerebral ischemia-reperfusion injury via PLA2G4A. Theranostics 12, 3196\u20133216. https:\/\/doi.org\/10.7150\/thno.71029 (2022).","journal-title":"Theranostics"},{"key":"33848_CR23","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1111\/andr.12764","volume":"8","author":"J Song","year":"2020","unstructured":"Song, J. et al. Protective effect of Berberine on reproductive function and spermatogenesis in diabetic rats via inhibition of ROS\/JAK2\/NFkappaB pathway. Andrology 8, 793\u2013806. https:\/\/doi.org\/10.1111\/andr.12764 (2020).","journal-title":"Andrology"},{"key":"33848_CR24","doi-asserted-by":"publisher","first-page":"107235","DOI":"10.1016\/j.intimp.2020.107235","volume":"91","author":"J Yang","year":"2021","unstructured":"Yang, J. et al. Paeonol derivative-6 attenuates inflammation by activating ZEB2 in acute liver injury. Int. Immunopharmacol. 91, 107235. https:\/\/doi.org\/10.1016\/j.intimp.2020.107235 (2021).","journal-title":"Int. Immunopharmacol."},{"key":"33848_CR25","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1038\/nrgastro.2016.185","volume":"14","author":"T Ueno","year":"2017","unstructured":"Ueno, T. & Komatsu, M. Autophagy in the liver: Functions in health and disease. Nat. Rev. Gastroenterol. Hepatol. 14, 170\u2013184. https:\/\/doi.org\/10.1038\/nrgastro.2016.185 (2017).","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"33848_CR26","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1080\/15548627.2021.1895658","volume":"18","author":"Y Filali-Mouncef","year":"2022","unstructured":"Filali-Mouncef, Y. et al. The menage a trois of autophagy, lipid droplets and liver disease. Autophagy 18, 50\u201372. https:\/\/doi.org\/10.1080\/15548627.2021.1895658 (2022).","journal-title":"Autophagy"},{"key":"33848_CR27","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1038\/cdd.2009.16","volume":"16","author":"J Zhang","year":"2009","unstructured":"Zhang, J. & Ney, P. A. Role of BNIP3 and NIX in cell death, autophagy, and mitophagy. Cell Death Differ. 16, 939\u2013946. https:\/\/doi.org\/10.1038\/cdd.2009.16 (2009).","journal-title":"Cell Death Differ."},{"key":"33848_CR28","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1080\/15548627.2015.1034410","volume":"11","author":"LR Lapierre","year":"2015","unstructured":"Lapierre, L. R., Kumsta, C., Sandri, M., Ballabio, A. & Hansen, M. Transcriptional and epigenetic regulation of autophagy in aging. Autophagy 11, 867\u2013880. https:\/\/doi.org\/10.1080\/15548627.2015.1034410 (2015).","journal-title":"Autophagy"},{"key":"33848_CR29","doi-asserted-by":"publisher","first-page":"101109","DOI":"10.1016\/j.redox.2019.101109","volume":"25","author":"HS Li","year":"2019","unstructured":"Li, H. S. et al. HIF-1alpha protects against oxidative stress by directly targeting mitochondria. Redox Biol. 25, 101109. https:\/\/doi.org\/10.1016\/j.redox.2019.101109 (2019).","journal-title":"Redox Biol."},{"key":"33848_CR30","doi-asserted-by":"publisher","first-page":"1767","DOI":"10.1080\/15548627.2017.1356977","volume":"13","author":"SH Kim","year":"2017","unstructured":"Kim, S. H. et al. Ezetimibe ameliorates steatohepatitis via AMP activated protein kinase-TFEB-mediated activation of autophagy and NLRP3 inflammasome inhibition. Autophagy 13, 1767\u20131781. https:\/\/doi.org\/10.1080\/15548627.2017.1356977 (2017).","journal-title":"Autophagy"},{"key":"33848_CR31","doi-asserted-by":"publisher","first-page":"2183026","DOI":"10.1155\/2016\/2183026","volume":"2016","author":"L Minutoli","year":"2016","unstructured":"Minutoli, L. et al. ROS-mediated NLRP3 inflammasome activation in brain, heart, kidney, and testis ischemia\/reperfusion injury. Oxid. Med. Cell Longev. 2016, 2183026. https:\/\/doi.org\/10.1155\/2016\/2183026 (2016).","journal-title":"Oxid. Med. Cell Longev."},{"key":"33848_CR32","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1080\/03602530500316254","volume":"37","author":"Y Ando","year":"2005","unstructured":"Ando, Y. & Hasegawa, Y. Clinical pharmacogenetics of irinotecan (CPT-11). Drug Metab. Rev. 37, 565\u2013574. https:\/\/doi.org\/10.1080\/03602530500316254 (2005).","journal-title":"Drug Metab. Rev."},{"key":"33848_CR33","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1002\/jcph.1275","volume":"59","author":"X Bao","year":"2019","unstructured":"Bao, X., Wu, J., Kim, S., LoRusso, P. & Li, J. Pharmacometabolomics reveals irinotecan mechanism of action in cancer patients. J. Clin. Pharmacol. 59, 20\u201334. https:\/\/doi.org\/10.1002\/jcph.1275 (2019).","journal-title":"J. Clin. Pharmacol."},{"key":"33848_CR34","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1007\/s00534-008-0016-z","volume":"16","author":"AZ Khan","year":"2009","unstructured":"Khan, A. Z., Morris-Stiff, G. & Makuuchi, M. Patterns of chemotherapy-induced hepatic injury and their implications for patients undergoing liver resection for colorectal liver metastases. J. Hepatobiliary Pancreat. Surg. 16, 137\u2013144. https:\/\/doi.org\/10.1007\/s00534-008-0016-z (2009).","journal-title":"J. Hepatobiliary Pancreat. Surg."},{"key":"33848_CR35","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.taap.2017.04.023","volume":"327","author":"E Marcolino Assis-Junior","year":"2017","unstructured":"Marcolino Assis-Junior, E. et al. Dual effect of silymarin on experimental non-alcoholic steatohepatitis induced by irinotecan. Toxicol. Appl. Pharmacol. 327, 71\u201379. https:\/\/doi.org\/10.1016\/j.taap.2017.04.023 (2017).","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"33848_CR36","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.1093\/abbs\/gmu097","volume":"46","author":"S Zhu","year":"2014","unstructured":"Zhu, S. et al. FGF21 treatment ameliorates alcoholic fatty liver through activation of AMPK-SIRT1 pathway. Acta Biochim. Biophys. Sin (Shanghai) 46, 1041\u20131048. https:\/\/doi.org\/10.1093\/abbs\/gmu097 (2014).","journal-title":"Acta Biochim. Biophys. Sin (Shanghai)"},{"key":"33848_CR37","doi-asserted-by":"publisher","first-page":"5672","DOI":"10.1002\/cam4.3086","volume":"9","author":"J Zhou","year":"2020","unstructured":"Zhou, J., He, Z., Ma, S. & Liu, R. AST\/ALT ratio as a significant predictor of the incidence risk of prostate cancer. Cancer Med. 9, 5672\u20135677. https:\/\/doi.org\/10.1002\/cam4.3086 (2020).","journal-title":"Cancer Med."},{"key":"33848_CR38","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1038\/nrendo.2014.35","volume":"10","author":"KH Kim","year":"2014","unstructured":"Kim, K. H. & Lee, M. S. Autophagy\u2013a key player in cellular and body metabolism. Nat. Rev. Endocrinol. 10, 322\u2013337. https:\/\/doi.org\/10.1038\/nrendo.2014.35 (2014).","journal-title":"Nat. Rev. Endocrinol."},{"key":"33848_CR39","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1083\/jcb.200412022","volume":"169","author":"M Komatsu","year":"2005","unstructured":"Komatsu, M. et al. Impairment of starvation-induced and constitutive autophagy in Atg7-deficient mice. J. Cell Biol. 169, 425\u2013434. https:\/\/doi.org\/10.1083\/jcb.200412022 (2005).","journal-title":"J. Cell Biol."},{"key":"33848_CR40","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.1038\/nature07976","volume":"458","author":"R Singh","year":"2009","unstructured":"Singh, R. et al. Autophagy regulates lipid metabolism. Nature 458, 1131\u20131135. https:\/\/doi.org\/10.1038\/nature07976 (2009).","journal-title":"Nature"},{"key":"33848_CR41","doi-asserted-by":"publisher","first-page":"5720","DOI":"10.1093\/emboj\/19.21.5720","volume":"19","author":"Y Kabeya","year":"2000","unstructured":"Kabeya, Y. et al. LC3, a mammalian homologue of yeast Apg8p, is localized in autophagosome membranes after processing. EMBO J. 19, 5720\u20135728. https:\/\/doi.org\/10.1093\/emboj\/19.21.5720 (2000).","journal-title":"EMBO J."},{"key":"33848_CR42","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1097\/SHK.0000000000000111","volume":"41","author":"CW Lin","year":"2014","unstructured":"Lin, C. W. et al. Complete activation of autophagic process attenuates liver injury and improves survival in septic mice. Shock 41, 241\u2013249. https:\/\/doi.org\/10.1097\/SHK.0000000000000111 (2014).","journal-title":"Shock"},{"key":"33848_CR43","doi-asserted-by":"publisher","first-page":"3820","DOI":"10.1016\/j.molcel.2021.06.003","volume":"81","author":"TTP Nguyen","year":"2021","unstructured":"Nguyen, T. T. P. et al. SREBP-1c impairs ULK1 sulfhydration-mediated autophagic flux to promote hepatic steatosis in high-fat-diet-fed mice. Mol. Cell 81, 3820\u20133832. https:\/\/doi.org\/10.1016\/j.molcel.2021.06.003 (2021).","journal-title":"Mol. Cell"},{"key":"33848_CR44","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1016\/j.gastrohep.2020.09.014","volume":"44","author":"Y He","year":"2021","unstructured":"He, Y. et al. Silencing HIF-1alpha aggravates non-alcoholic fatty liver disease in vitro through inhibiting PPAR-alpha\/ANGPTL4 singling pathway. Gastroenterol. Hepatol. 44, 355\u2013365. https:\/\/doi.org\/10.1016\/j.gastrohep.2020.09.014 (2021).","journal-title":"Gastroenterol. Hepatol."},{"key":"33848_CR45","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1007\/s12031-018-1162-7","volume":"66","author":"N Lu","year":"2018","unstructured":"Lu, N. et al. HIF-1alpha\/Beclin1-mediated autophagy is involved in neuroprotection induced by hypoxic preconditioning. J. Mol. Neurosci. 66, 238\u2013250. https:\/\/doi.org\/10.1007\/s12031-018-1162-7 (2018).","journal-title":"J. Mol. Neurosci."},{"key":"33848_CR46","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/j.ejphar.2018.03.002","volume":"827","author":"T Fu","year":"2018","unstructured":"Fu, T. et al. Protective effects of alpha-mangostin against acetaminophen-induced acute liver injury in mice. Eur. J. Pharmacol. 827, 173\u2013180. https:\/\/doi.org\/10.1016\/j.ejphar.2018.03.002 (2018).","journal-title":"Eur. J. Pharmacol."},{"key":"33848_CR47","doi-asserted-by":"publisher","first-page":"2021","DOI":"10.1016\/j.jaci.2021.04.018","volume":"147","author":"L Wang","year":"2021","unstructured":"Wang, L., Sharif, H., Vora, S. M., Zheng, Y. & Wu, H. Structures and functions of the inflammasome engine. J. Allergy Clin. Immunol. 147, 2021\u20132029. https:\/\/doi.org\/10.1016\/j.jaci.2021.04.018 (2021).","journal-title":"J. Allergy Clin. Immunol."},{"key":"33848_CR48","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1111\/imr.12286","volume":"265","author":"EI Elliott","year":"2015","unstructured":"Elliott, E. I. & Sutterwala, F. S. Initiation and perpetuation of NLRP3 inflammasome activation and assembly. Immunol. Rev. 265, 35\u201352. https:\/\/doi.org\/10.1111\/imr.12286 (2015).","journal-title":"Immunol. Rev."},{"key":"33848_CR49","doi-asserted-by":"publisher","first-page":"1526","DOI":"10.1002\/hep.24256","volume":"53","author":"B Nath","year":"2011","unstructured":"Nath, B. et al. Hepatocyte-specific hypoxia-inducible factor-1alpha is a determinant of lipid accumulation and liver injury in alcohol-induced steatosis in mice. Hepatology 53, 1526\u20131537. https:\/\/doi.org\/10.1002\/hep.24256 (2011).","journal-title":"Hepatology"},{"key":"33848_CR50","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/j.neuroscience.2020.09.036","volume":"448","author":"Q Jiang","year":"2020","unstructured":"Jiang, Q. et al. Hypoxia inducible factor-1alpha (HIF-1alpha) mediates NLRP3 inflammasome-dependent-pyroptotic and apoptotic cell death following ischemic stroke. Neuroscience 448, 126\u2013139. https:\/\/doi.org\/10.1016\/j.neuroscience.2020.09.036 (2020).","journal-title":"Neuroscience"},{"key":"33848_CR51","doi-asserted-by":"publisher","first-page":"4763","DOI":"10.1073\/pnas.1620458114","volume":"114","author":"N Gupta","year":"2017","unstructured":"Gupta, N. et al. Activation of NLRP3 inflammasome complex potentiates venous thrombosis in response to hypoxia. Proc. Natl. Acad. Sci. U. S. A. 114, 4763\u20134768. https:\/\/doi.org\/10.1073\/pnas.1620458114 (2017).","journal-title":"Proc. Natl. Acad. Sci. U. S. A."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-33848-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-33848-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-33848-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,21]],"date-time":"2023-04-21T06:12:03Z","timestamp":1682057523000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-33848-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,21]]},"references-count":51,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["33848"],"URL":"https:\/\/doi.org\/10.1038\/s41598-023-33848-y","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,4,21]]},"assertion":[{"value":"24 October 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 April 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 April 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"6528"}}